Comparing acceptance of smoking cessation and smoke-free home intervention offers and associated factors among people with low income in the USA: baseline results of a randomised controlled trial

Author:

McQueen AmyORCID,Wolff Jennifer,Grimes Lauren,Teshome Enguday,Garg Rachel,Thompson Tess,Carpenter Kelly,Kegler Michelle C,Kreuter Matthew W

Abstract

IntroductionState tobacco quitlines are the most commonly available smoking cessation programmes; however, they have low reach and typically only enrol people who are ready to quit in the next 30 days. Expanding quitline services may increase the total number of people engaged in tobacco control efforts and the number who eventually quit. In this randomised controlled trial, we offered both arms a tobacco quitline intervention. In arm 2, if they declined the quitline, we then offered a smoke-free home (SFH) intervention. We examined the number of participants who accepted each intervention offer at baseline and whether acceptance varied by participant characteristics.MethodsWe recruited 1982 people who called 211, a social services helpline for social needs; mean age=50, 68% female; 45% white, 41% black and 14% other race/ethnicity; 68% reported an annual household income <US$20 000.ResultsIn each arm, 59.7% of participants accepted the quitline offer. In arm 2, among those who declined the quitline offer, 53.1% accepted the SFH intervention offer. Thus, an additional 212 (21.4% of all arm 2 participants) people who smoke engaged in tobacco control programmes than would have with standard practice alone (quitline only). Acceptance differed by participant characteristics: males were less likely than females to accept either offer. Whites were less likely, and older adults and those with greater nicotine dependence were more likely, to accept the quitline offer.ConclusionsProactive approaches identified many low-income people who smoke and offering an SFH intervention retained many more of them in tobacco control efforts. Future trial results will assess intervention engagement and effects on cessation.Trial registration numberClinicalTrials.gov identifierNCT04311983.

Funder

Division of Cancer Prevention, National Cancer Institute

Publisher

BMJ

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3